BAM
ABBV icon

Bosun Asset Management’s AbbVie ABBV Stock Holding History

Bosun Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$46.3K – 80
2025
Q3 		$46.3K Hold
200
– – 0.02% 70
2025
Q2 		$37.1K Hold
200
– – 0.01% 195
2025
Q1 		$41.9K Hold
200
– – 0.02% 192
2024
Q4 		$35.5K Buy
+200
New +$36.8K 0.02% 187

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bosun Asset Management's ABBV Position: Q1 2026 in Review

Bosun Asset Management held its AbbVie (ABBV) position steady in Q1 2026 at 3,661 shares worth $796K. The position accounts for 0.43% of the portfolio, ranked #33.

Bosun Asset Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.32M in Q1 2023. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bosun Asset Management held 3,661 shares of AbbVie worth $796K as of Q1 2026.
  • Bosun Asset Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.43% of Bosun Asset Management's portfolio in Q1 2026, its #33 holding.
  • Bosun Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Bosun Asset Management's AbbVie position peaked at $1.32M in Q1 2023.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bosun Asset Management's 13F filing for Q1 2026, filed 11 May 2026.